SGI
IART icon

Summit Global Investments’s Integra LifeSciences IART Stock Holding History

Summit Global Investments’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,419
Closed -$374K – 586
2021
Q1 		$374K Buy
+5,419
New +$367K 0.02% 413

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Summit Global Investments's IART Position: Q2 2021 in Review

Summit Global Investments sold out of Integra LifeSciences (IART) in Q2 2021, closing a stake of 5,419 shares — an estimated $374K sold.

Summit Global Investments first reported a position in IART in Q1 2021 and held it in 1 quarter. The position peaked at $374K in Q1 2021. 264 funds tracked by Wall St. Rank hold IART as of Q2 2021.

  • Summit Global Investments reported no remaining Integra LifeSciences position as of Q2 2021 after selling out during the quarter.
  • Summit Global Investments sold 5,419 Integra LifeSciences shares in Q2 2021, an estimated $374K.
  • Summit Global Investments first reported a position in Integra LifeSciences in Q1 2021 and held it in 1 quarter.
  • Summit Global Investments's Integra LifeSciences position peaked at $374K in Q1 2021.
  • 264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2021.

Based on Summit Global Investments's 13F filing for Q2 2021, filed 28 Jan 2022.